England vs Wales — key differences in pharmacy regulation
How the pharmacy regulatory frameworks in England and Wales differ, and why it matters for applications.
Different regulations
England: applications are governed by the NHS (Pharmaceutical and Local Pharmaceutical Services) Regulations 2013, as amended. Wales: the NHS (Pharmaceutical Services) (Wales) Regulations 2020 apply. The two sets of regulations differ in structure, application routes, timescales and assessment criteria. Advice based on the English regulations will not necessarily be correct for Wales, and vice versa.
Different decision-makers
In England, applications are determined by integrated care boards (ICBs) under delegation from NHS England, with administration through PCSE. In Wales, applications are made to local health boards (LHBs), which make decisions directly. There is no PCSE equivalent in Wales.
Pharmaceutical needs assessments
Both England and Wales use pharmaceutical needs assessments as part of the application process, but the frameworks differ. In Wales, LHBs are responsible for producing and maintaining their own PNAs under the Welsh regulations.
Appeals
In England, appeals go to NHS Resolution's Primary Care Appeals service. In Wales, the appeals structure differs and is administered under the Welsh framework. An adviser with experience of both jurisdictions is important where a pharmacy operates, or is proposed, near the England-Wales border.
A note on Scotland and Northern Ireland
Scotland and Northern Ireland have entirely separate pharmacy regulatory frameworks. TI Pharmacy Consultancy advises on England and Wales only.
Frequently asked questions
Yes. The pharmacy regulatory frameworks in England and Wales are sufficiently different that advice based solely on one jurisdiction's rules will not necessarily be correct for the other. Key differences include the governing regulations, the bodies that administer and decide applications, the application routes and criteria, and the appeals process. TI Pharmacy Consultancy advises on both jurisdictions and ensures applications are prepared specifically for the correct regulatory framework.
The regulations that apply depend on where your pharmacy premises are located — not where you live or where your patients come from. If your pharmacy is in England, the NHS (Pharmaceutical and Local Pharmaceutical Services) Regulations 2013 apply. If it is in Wales, the NHS (Pharmaceutical Services) (Wales) Regulations 2020 apply. For pharmacies near the border, the position is determined by the precise location of the premises.
No. Both England and Wales use pharmaceutical needs assessments as part of the application process, but the frameworks differ. In England, PNAs are produced by health and wellbeing boards. In Wales, local health boards produce and maintain their own PNAs under the Welsh regulations. The structure, content requirements and how PNAs are used in application decisions differ between the two jurisdictions.
The regulatory framework that applies is determined by where your pharmacy is located, not where your patients come from. However, cross-border pharmacies may face particular considerations in terms of service provision and local pharmaceutical needs. TI Pharmacy Consultancy has experience of advising on cross-border pharmacy matters and can advise on the specific implications for your pharmacy.
No. Opening hours obligations and the process for varying them differ between England and Wales. In particular, the dual-route framework introduced in England in June 2025 does not apply in Wales, where a different process applies under the Welsh regulations. TI Pharmacy Consultancy advises on the correct process for opening hours applications in each jurisdiction.
Need professional advice?
The information above is for general awareness only. For advice specific to your situation, contact TI Pharmacy Consultancy for a free initial discussion.
Contact us